White Paper: Phenotypic Screening
This white paper, analyzes the pros and cons of target and phenotypic screening and explains why top pharmaceutical companies are implementing a more holistic and balanced approach for accelerating drug discovery.
It highlights the advantages of using the Intellicyt platform over traditional flow cytometry and imaging systems.
